Clinical Trials

Related by string. clinical trials * clinicals : Phase III clinical trials / trial : Week Premium Trial * Phase III Clinical Trial . placebo controlled clinical trials . randomized clinical trials . randomized controlled clinical trials . clinical pharmacology clinical trials . IIa clinical trial . Phase IIa clinical trials . Clinical Trial Results . Clinical Trial Application *

Related by context. All words. (Click for frequent words.) 75 Clinical Trial 63 Autoimmune Disease 62 Clinical 61 Protein Therapeutics 61 Clinical Research 61 Patient Recruitment 61 Phase III Clinical Trial 61 Clinical Study 61 Hepatocellular Carcinoma 60 Cancer Immunotherapy 60 Vaccine Trials 60 Clinical Trial Results 60 Renal Cancer 60 Autoimmune Diseases 60 Phase IIb Clinical Trial 60 Phase 2b Clinical Trial 60 Bladder Cancer 59 Therapeutic Antibodies 59 Biomarker 59 Hematologic Malignancies 59 Metabolic Disease 59 Phase III Trials 59 Metabolic Disorders 59 Drug Discovery 59 Hepatitis C Virus 59 Phase III Trial 59 Pharmacogenomic 59 Influenza Vaccine 59 Molecular Diagnostic 59 Radiation Treatment 58 Genetic Testing 58 HCV Protease Inhibitor 58 Phase III Clinical Trials 58 Patient Outcomes 58 Gastric Cancer 58 clinical trials 58 Small Molecule 58 Pivotal Trial 58 Targeted Therapies 58 Pivotal Trials 58 II Clinical Trial 58 Smooth Muscle 58 Inflammatory Arthritis 58 Stem Cell Treatment 57 Prostate Cancer Treatment 57 Present Preclinical Data 57 Breast Cancer Treatment 57 Drug Delivery 57 Novel Therapies 57 Myelodysplastic Syndromes 57 Pharmacogenetics 57 Cancer Therapies 57 Electrophysiology Mapping 57 Immunotherapeutic 57 Antisense Drug 57 clinical trial 57 Phase 2b Study 57 Cancer Vaccine 57 Patients Treated With 57 Lung Cancer Drug 57 Early Diagnosis 57 Clinical Trial Data 57 Phase 2a Trial 57 Laryngeal Cancer 57 Therapeutic Monoclonal Antibodies 57 Phase IIb Trial 57 Combination Treatment 57 Cancer Vaccines 57 Patient Enrollment 57 Pulmonary Arterial Hypertension 57 Initiates Clinical Trial 57 Protein Interaction 57 Lung Cancer Trial 57 Drug Candidate 57 Liver Cancer 57 Antibody Therapeutics 57 Monoclonal Antibodies 57 Orphan Diseases 57 Emerging Therapies 57 Neurodegenerative Disease 57 Insulin Delivery 57 Initiate Clinical Trial 56 Cancer Biomarkers 56 Improves Survival 56 Genetic Diseases 56 Prolongs Survival 56 Asthma COPD 56 Clinical Evaluation 56 Diagnostic Tests 56 RNAi Therapeutics 56 IND Filing 56 Vascular Targeting Agents 56 Biopharmaceutical Industry 56 Preclinical Models 56 Urinary Incontinence 56 Clinical Trial Evaluating 56 Therapeutic Vaccine 56 Stem Cell Transplant 56 Therapeutic Antibody 56 BiTE Antibody 56 Fabry Disease 56 Maven Semantic 56 Cancer Biomarker 56 Investigational Drug 56 Hematological Malignancies 56 Preclinical Development 56 Drug Pipeline 56 Rheumatoid Arthritis Patients 56 Pharmacogenomics 56 Epidemiological Studies Unit 56 Immunotherapeutics 56 Seasonal Influenza Vaccine 56 Cancer Treatments 56 Novel Therapeutics 56 Investigational Treatment 56 Prenatal Diagnosis 56 Molecular Diagnostics 56 Clinical Outcome 56 Overactive Bladder 56 Kinase Inhibitor 56 Drug Shows Promise 56 RNAi Therapeutic 56 Biomarker Study 56 Acute Decompensated Heart Failure 56 NABTT 56 Preclinical Data 56 Molecular Diagnostic Test 56 Subgroup Analysis 56 Shows Efficacy 56 Novel Approaches 55 Pivotal Phase III 55 Treatment Resistant 55 Completes Patient Enrollment 55 Heart Failure Patients 55 Novel Small Molecule 55 Pharm Olam International 55 Phase IIa Clinical Trial 55 Neurodegenerative 55 Cell Signaling 55 Presents Positive 55 Diagnosis Treatment 55 Autoimmune 55 Advanced Melanoma 55 Genitourinary 55 Immune Cell 55 Biological Therapy 55 Prospective Randomized 55 Osteoarthritis Pain 55 Personalised Medicine 55 Newly Diagnosed 55 Oral Interferon 55 Anti Infectives 55 Receives Orphan Drug Designation 55 Pivotal Study 55 Nuclear Receptors 55 Randomized Study 55 Multiple Myeloma Patients 55 Hypercholesterolemia 55 Tumor Response 55 Tuberculosis Vaccine 55 Ovarian Cancer Patients 55 Initiates Phase III 55 Non Invasive 55 Acute Ischemic Stroke 55 Gastrointestinal Disorders 55 Companion Diagnostics 55 Neurotherapeutics 55 Vaccine Adjuvant 55 Anti CD# Antibody 55 Lupus Drug 55 Therapeutic Potential 55 Severe Sepsis 55 Therapeutic Vaccines 55 Combination REOLYSIN R 55 Gene Expression Profiling 55 Vascular Disease 55 Anticoagulant 55 Gastrointestinal Cancer 55 Successfully Completes Phase 55 Pooled Analysis 55 Inflammatory Diseases 55 Inhaled Liposomal Ciprofloxacin 55 Anti Tumor 55 Pneumococcal Vaccine 55 Drug Metabolism 55 Chronic Lymphocytic Leukemia 55 Oral Fingolimod 55 IL# PE#QQR 55 Completes Enrollment 55 Oncologic 55 Phase Ib II 55 Anti Angiogenesis 54 Anticancer Drug 54 Antiepileptic Drug 54 Venous Thromboembolism 54 Postmenopausal Women 54 Pivotal Phase 54 Vaccine Trial 54 Hematological Cancers 54 Immunotherapies 54 Presents Preclinical Data 54 Meets Primary Endpoint 54 Ophthalmic Drug 54 Avian Flu Vaccine 54 Oncology Drug 54 Drug Repositioning 54 Clinical Outcomes 54 Cardiovascular Outcomes 54 Novel Treatments 54 Systemic Sclerosis 54 Genes Involved 54 Recombinant Protein 54 Receives Orphan Drug 54 Gastrointestinal Oncology 54 Inflammatory Disease 54 Tissue Repair 54 Colorectal Cancer Screening 54 Genetic Disorders 54 Therapy Evaluation 54 IIa clinical 54 Malaria Vaccine 54 Clinical Pharmacology 54 Neuroprotection 54 Functional Genomics 54 ENDEAVOR IV 54 Cardiovascular Therapeutics 54 Prostate Cancer Vaccine 54 Investigational Compound 54 Pivotal Clinical Trial 54 Rheumatoid Arthritis Drug 54 Liver Disease 54 Organ Transplantation 54 number NCT# ClinicalTrials.gov 54 Vitro Diagnostics 54 Therapeutic Targets 54 Cardiovascular Devices 54 Rotavirus Vaccine 54 Cutaneous T 54 Phase 1b Clinical Trial 54 Pathogenesis 54 Epilepsy Drug 54 ECTRIMS 54 Advanced Pancreatic Cancer 54 JAK Inhibitor 54 Preclinical Studies 54 Rheumatoid Arthritis 54 Drug Eluting Stent 54 Cardiometabolic 54 Neoplasia 54 Improve Survival 54 Erythropoietic 54 Previously Treated 54 Prostate Cancer Patients 54 Heart Transplant Recipients 54 ASH Annual Meeting 54 Ichor Medical Systems 54 Metabolic Diseases 54 VIVUS Qnexa 54 Pandemic Influenza Vaccines 54 Cardiovascular Diseases 54 Pharmacovigilance 54 Phase IIIb 54 Anticancer Activity 54 Investigational Agent 54 Randomized Controlled 54 Enrolling Patients 54 IIa Clinical Trial 54 Oral Presentations 54 Randomized Controlled Trials 54 Solid Tumors 54 Universal Flu Vaccine 54 Arthritis Drug 54 Smallpox Vaccine 54 Granted Orphan Drug 54 Biomarker Discovery 54 Cancer Therapeutic 54 Lung Injury 54 Coronary Revascularization 54 Advanced Renal Cell 54 Demonstrates Sustained 54 Diabetes Obesity 54 Diabetic Patients 54 Metastatic Melanoma 53 Guidelines Issued 53 Brentuximab Vedotin SGN 53 Receives Positive Opinion 53 Cardiac Rhythm 53 Psoriasis Drug 53 Image Guided 53 Tissue Engineering 53 Study Evaluating 53 Immune Mediated 53 Companion Diagnostic 53 Preclinical Study 53 Poster Presentations 53 Cloretazine ® 53 Inhaled Insulin 53 Multicenter Randomized 53 Demonstrates Potent 53 Phase III Pivotal 53 Hemorrhagic Stroke 53 Dendritic Cells 53 Anti Infective 53 Initiate Phase II 53 Genes Identified 53 Pipeline Analysis 53 Platelet Inhibition 53 Cancer Therapy 53 Kidney Transplantation 53 Protein Interactions 53 Schizophrenia Drug 53 Ozarelix 53 Initiates Clinical 53 NDA Submission 53 Begins Clinical Trial 53 Study ADCS 53 Movement Disorder 53 Gaucher Disease 53 Personalized Immunotherapy 53 Osteoporosis Treatment 53 Survival Benefit 53 Antiviral Therapy 53 Dupuytren Contracture 53 Arthritis Drugs 53 Toxicogenomics 53 Osteoarthritis Patients 53 Renal Anemia 53 Immune Therapy 53 Intravenous Formulation 53 Hospitalized Patients 53 Bipolar Depression 53 Viral Infections 53 Improve Outcomes 53 Outcome Sciences 53 Initiates Clinical Trials 53 Clinical Efficacy 53 Acute Heart Failure 53 Analytical Tool 53 Multidrug Resistant 53 Synthetic Peptide 53 Diabetic Retinopathy 53 Remote Patient Monitoring 53 Improves Outcomes 53 Drug Approvals 53 Treating Heart Failure 53 Chronic Hepatitis C 53 Files IND 53 Pharmacoeconomics 53 Small Molecules 53 Meta Analysis 53 Gastrointestinal Cancers 53 Patients Enrolled 53 Nonclinical 53 Treating Depression 53 Therapeutic Approaches 53 Chemotherapeutic Agents 53 Genomic Medicine 53 Bone Marrow Transplantation 53 Observational Studies 53 Systemic Delivery 53 ASCO Annual Meeting 53 Initiate Phase 53 Antiplatelet Therapy 53 Proteomics 53 Chemoprevention 53 Reports Preclinical Data 53 Anti Tumor Activity 53 Risk Stratification 53 Biosimilars 53 Relapsing Multiple Sclerosis 53 Stem Cell Transplants 53 Oligonucleotides 53 Immunosuppressant 53 Long Term Efficacy 53 Shows Promising 53 Topline Results 53 Infected Patients 53 Immunogenicity 53 Hemodialysis Patients 53 Collaborators Publish 53 Dual Antiplatelet Therapy 53 Sipuleucel T 53 Neck Cancer 53 Infectious Disease 53 Advanced Prostate Cancer 53 Cytometry 53 See CLINICAL PHARMACOLOGY 53 Osteoporosis Drug 53 CNS Therapeutics 53 Surgical Procedures 53 Human Embryonic Stem 53 Islet Transplantation 53 Tumor Targeting 53 Demonstrates Positive 53 Dose Escalation 53 M.D. Ph.D. 53 Aneurysm Repair 53 Hematopoietic Stem Cell Transplantation 53 Adjuvant Breast Cancer 53 Cognitive Disorders 53 Pharmacokinetic Study 53 Cervical Dysplasia 53 Slow Progression 53 Observational Study 53 FOLOTYN ® 53 Nicotine Vaccine 53 Max Neeman International 53 Diabetic Foot Ulcer 53 DNA Sequencing 53 Immunomedics Announces 53 Treating Chronic 53 Minimally Invasive Treatment 53 Trial Evaluating 53 Metabolomics 53 Completes Patient Enrolment 53 Pafuramidine 53 Neurodegenerative Diseases 53 Neuropathic Pain 52 Prevalence Estimates 52 Oral Insulin Capsule 52 JAK2 Inhibitor 52 Monoclonal Antibody 52 Nymox NX 52 PharmaVitae Profile 52 Breast Cancer Detection 52 Cell Transplant 52 C1 Inhibitor 52 Confirmatory Phase 52 Stakeholder Insight 52 Prospective Multicenter 52 ISPOR 52 Biotech Pharma 52 Schizophrenia Treatment 52 Novel Vaccine 52 TB Vaccine 52 Anemia Drug 52 Pivotal Phase II 52 Adjuvant Chemotherapy 52 Clinical Pharmacy 52 Thyroid Cancer 52 Dialysis Patients 52 Sapacitabine 52 Cancer Therapeutics 52 clinical 52 Etiology 52 Initiates Enrollment 52 Kidney Disease 52 Psychiatric Disorders 52 Initiates Phase II 52 Pancreatic Adenocarcinoma 52 Bipolar Disorders 52 Renal Cell Carcinoma 52 Malignant Melanoma 52 Biostatistical 52 Treatment Approaches 52 Hepatitis B Vaccine 52 Injectable Drug 52 Drug Fails 52 Iron Overload 52 Kidney Transplants 52 Interferon Alpha 52 Maven Semantic http:/www.mavensemantic.com announBruising Brandon 52 Treatment Options 52 Antiangiogenic 52 Randomized Clinical Trial 52 Confirms Efficacy 52 IND Application 52 Diabetic Nephropathy 52 Hsp# Inhibitor 52 Antifungals 52 Medication Errors 52 Study Evaluates 52 Clinical Trials Review 52 Pulmonary Hypertension 52 Immunodeficiencies 52 Disease Modifying 52 Pediatric Cardiac 52 Stem Cell Treatments 52 ASM Biodefense 52 Improved Survival 52 Endovascular Treatment 52 Disease Progression 52 Adjuvant Treatment 52 Cell Lung Cancer 52 Clinical Trials Unit 52 ICAAC IDSA 52 Cord Blood Banking 52 Files Investigational 52 Statin Therapy 52 Investigational Drugs 52 Unresectable 52 Phase 2a Clinical Trial 52 Immunosuppressive 52 Chronic Heart Failure 52 Treatment Naive Patients 52 Preterm Labor 52 Population Genomics 52 Soft Tissue Sarcoma 52 Liver Transplantation 52 Initiates Phase 2b 52 bioRASI 52 Drug Eluting Stents 52 Patients Receiving 52 Chronic Lymphocytic Leukemia CLL 52 Cardiac Arrhythmia 52 Respiratory Virus 52 Influenza Vaccines 52 Prostate Cancers 52 FDA Approvals 52 entitled Formulary Advantages 52 Interstitial Cystitis 52 Lung Cancer Patients 52 Genetic Predisposition 52 Proves Effective 52 Diagnostic Criteria 52 Immunologic 52 Bioequivalence 52 ImmunoCellular Therapeutics 52 Insulin Resistance 52 Kinase Inhibitors 52 Genes Linked 52 Islet Transplant 52 Phase 2b Trial 52 Pneumococcal Disease 52 Receives Milestone Payment 52 FDA Accepts 52 Clinical Guideline 52 Anticoagulation 52 Novel Therapeutic 52 Antiviral 52 Anticancer Agent 52 Breast Cancer Recurrence 52 Bone Marrow Transplants 52 Antibody Discovery 52 Erectile Dysfunction Drug 52 Aryplase 52 Biopharmaceutical Manufacturing 52 Heart Transplantation 52 Diabetes Complications 52 Surgical Treatment 52 Hormone Refractory Prostate Cancer 52 stage hypoxia activated 52 Hepatitis C Treatment 52 Estrogen Therapy 52 DAPT Study 52 Hedgehog Pathway Inhibitor 52 Tyrosine Kinase Inhibitor 52 Investigator Initiated 52 Oncology 52 RNA Interference 52 Advanced Heart Failure 52 Movement Disorders 52 Valvular Heart Disease 52 Receives Marketing Authorization 52 Individualized Treatment 52 Orphan Drugs 52 Allergic Rhinitis 52 Anticancer Agents 52 Seasonal Influenza 52 Shows Promise Against 52 Hormone Therapy 52 MEK Inhibitor 52 Therapeutics Roundtable 52 Drug Resistant 52 Late Breaker 52 Biomarkers 52 Adverse Outcomes 52 Benign Prostatic Hyperplasia 52 Feasibility Trial 52 Biologics Manufacturing 52 Tissue Engineered 52 Pharma Biotech 52 AFREZZA TM 52 Renal Artery 52 MKC# MKC# PP 52 Breast Tumor 52 Chronic Diseases 52 Metabolic Disorder 52 Male Infertility 52 Antithrombotic 52 Antitumor Activity 52 Autologous Stem Cell Transplantation 52 Peritoneal Dialysis 52 Dyslipidemia 52 Genetic Disease 52 Therapeutic Advances 52 Elderly Patients 52 Fungal Infections 52 Completes Dosing 51 Advanced Colorectal Cancer 51 DNA Methylation 51 Clinical Validation 51 SABCS 51 Virus Infection 51 Bio Pharmaceutical 51 Heart Failure Treatment 51 Aurora Kinase 51 Hematological 51 Safinamide 51 Angiogenesis 51 Glucose Monitoring 51 Tumor Markers 51 Successfully Treats 51 Stem Cells 51 Myocet 51 Infectious Disease Testing 51 Bone Metastases 51 Gene Mutation 51 Reperfusion Injury 51 Collaborators Present 51 Chronic Myeloid Leukemia 51 Solid Malignancies 51 Drug Eluting 51 Renal Transplant 51 Gene Silencing 51 Antipsychotic Drug 51 Phase Ib Clinical Trial 51 Multicenter Study 51 Metastatic Colorectal Cancer 51 Patient Enrolment 51 Recombinant Human 51 Resistant Hypertension 51 Neuroendocrine Tumors 51 Biopharma 51 Molecular Oncology 51 Versus Placebo 51 Veterinary Vaccines 51 HER2 Positive 51 Clinically Significant 51 Demonstrates Ability 51 Molecular Virology 51 Protease Inhibitors 51 Nonalcoholic Steatohepatitis 51 Novel Antibiotic 51 Inhibits Growth 51 identifier NCT# 51 Glatiramer Acetate 51 Gene Expression 51 Heart Failure Therapy 51 Thyroid Hormone 51 Gene Therapy Trial 51 Peripheral Arterial Disease 51 Breast Ultrasound 51 Novel Inhibitor 51 Successfully Treated 51 Improve Diagnosis 51 Advanced Ovarian Cancer 51 Adverse Event 51 Pain Medication 51 Presents Positive Preclinical 51 Commence Phase 51 HER2 Positive Breast Cancer 51 Ocular Diseases 51 Cytology 51 ERYtech 51 Asthma Treatment 51 Therapeutic Apheresis 51 NICE Recommends 51 Treat Anemia 51 Liver Toxicity 51 Drug Eluting Coronary Stent 51 Cancer Stem Cells 51 Immunotherapy 51 Postmenopausal Osteoporosis 51 Autoimmunity 51 Outcomes Research 51 Oral Insulin 51 Quark Pharmaceuticals 51 Blood Pressure Lowering 51 Clinical Effectiveness 51 pharmacogenomic translational research 51 Biologic Therapy 51 Randomized Phase 51 Anti Clotting Drug 51 Begin Clinical Trials 51 Cardiovascular Disease 51 Stent Thrombosis 51 Interstitial Lung Disease 51 Antiviral Activity 51 Gout Drug 51 Arterial Disease 51 Multicenter Phase 51 Comparative Effectiveness 51 Rare Diseases 51 Acute Coronary Syndromes ACS 51 Inherited Disease Research 51 Progenitor Cells 51 Eye Diseases 51 CDISC Interchange 51 AIDS Clinical Trials 51 Topical Treatment 51 Cholesterol Drug 51 BioPharm 51 TG MV 51 Stakeholder Opinions 51 Mouse Models 51 Clinical Dermatology 51 Ischemic Stroke 51 Urogynecology 51 Glycemia 51 Systemic Lupus Erythematosus 51 FDA Approves Drug 51 Molecular Medicine Tri 51 Genome Sequencing 51 Blood Cancers 51 Neurodegenerative Disorders 51 Insulin Pumps 51 External Defibrillators 51 Malignancies 51 Antipsychotic Medications 51 Stem Cell Transplantation 51 Molecular Pathogenesis 51 Gene Linked 51 Therapeutic Efficacy 51 Bio Pharma 51 Antiretroviral Treatment 51 Chronic Hepatitis B 51 Oxidative Stress 51 Retrovirus 51 Preclinical 51 Mitochondrial Medicine 51 Trodusquemine MSI 51 First Patient Treated 51 Chronic Renal Failure 51 Hormone Replacement 51 Milestone Payment 51 Cell Signalling 51 Pemphigus Vulgaris 51 AIDS Vaccine 51 Cost Effectiveness 51 Transdermal Delivery 51 Pharmacoeconomic 51 Biobanking 51 Nanobiotechnology 51 Gynecologic 51 Novel Oral 51 LSE ASM 51 Novel Mechanism 51 Premature Ejaculation 51 Interventional Cardiovascular 51 Hepatobiliary 51 Molecular Basis 51 Preclinical Efficacy 51 Mitral Valve Repair 51 Acute Pain 51 Interferon Alfa 51 Surgical Mesh 51 Musculoskeletal Diseases 51 Oligonucleotide 51 Blood Pressure Drug 51 Cardiac Electrophysiology 51 Cell Differentiation 51 SUTENT ® 51 Genetic Screening 51 Treatment Reduces 51 Protein Expression 51 Capsule Endoscopy 51 Marketing Authorisation Application 51 Severe Asthma 51 Oral Cladribine 51 Prostate Biopsy 51 Cervical Cancer Vaccine 51 Vascular Access 51 Anti infective 51 Cardiotoxicity 51 Phase III Pivotal Trial 51 Kidney Transplant Recipients 51 Genetic Tests 51 Fast Track Status 51 LUMINATE 51 Improving Outcomes 51 Cardiovascular Monitoring 51 Ceflatonin R 51 First Patient Enrolled 51 Study Validates 51 Elagolix 51 Patients Treated 51 Flu Vaccines 51 FDA Okays 51 HORIZONS AMI 51 Radiopharmaceutical 51 Omacetaxine 51 Upcoming Webinar 51 Treatment Experienced 51 Biosimilar 51 Atopic Dermatitis 51 Cord Blood Stem Cells 51 Announces Poster Presentations 51 Implantable Device 51 ID NCT# 51 Personalized Medicine 51 Dose Ranging 51 Solid Tumor 51 Chronic Constipation 51 Factor VIIa 51 Weight Loss Drug 51 Enters Into Collaboration 51 Guidelines Recommend 51 Microplasmin 51 Ocular Disease 51 Acute Stroke 51 Acute Coronary Syndromes 51 Total Knee Arthroplasty 51 Kidney Function 51 Surgery Performed 51 Chronic Inflammation 51 Hormonal Therapy 51 ABRF 51 Zenvia Phase III 51 Uterine Fibroid Embolization 51 ST Segment Elevation 51 Refractory Angina 51 Gastrointestinal Disease 51 Small Molecule Drug 51 Preclinical Testing 51 Cardiac Catheterization 51 Vitro Diagnostic 51 AVI BioPharma Announces 51 Patients Suffering 51 Edge STudy 51 Protease Inhibitor 51 CyberKnife Radiosurgery 50 Predictive Toxicology 50 Orphan Status 50 Stronger Warnings 50 Therapeutic Proteins 50 Bird Flu Vaccine 50 Initiates Dosing 50 Reduce Mortality 50 Inhalation Solution 50 Antiretroviral Drug 50 Investigational 50 Newly Diagnosed Multiple Myeloma 50 Mesothelioma Treatment 50 AACR Meeting 50 Glaucoma Treatment 50 Provides Detailed 50 Colorectal Adenomas 50 Protein Synthesis 50 Surgical Equipment 50 Post Operative 50 FDA Clears 50 Hospital Acquired Pneumonia 50 Transdermal Patch 50 Myocardial Infarction 50 ONGLYZA TM 50 Drug Makers 50 Treatment Regimen 50 Angiogenic 50 Microbicide 50 Vaccine Protects Against 50 Combination Therapy 50 Drug Combo 50 Pandemic Influenza Vaccine 50 Psoriasis Patients 50 Vitro Diagnostics Market 50 Cachexia 50 Slows Progression 50 Gene Therapy 50 XIENCE V Stent System 50 Immunology 50 HPV Vaccines 50 Treatment Outcome 50 HPV Vaccination 50 Contrast Echocardiography 50 Randomized Double blind 50 NCI Cancer 50 Spinal Fusion 50 Neuroprotective Effects 50 Obesity Surgery 50 Signal Transduction 50 Alternative Treatments 50 Gynecol Oncol 50 Reveals Positive 50 Inflammatory Bowel Disease 50 Recurrent Breast Cancer 50 BIO Windhover 50 Breast Cancer Survival 50 Respiratory Infections 50 Windhover Conferences 50 Myelofibrosis 50 Diabetes Endocrine 50 Cardiac Marker 50 Gene Expression Analysis 50 Neoadjuvant Chemotherapy 50 Bioanalysis 50 Male Contraceptive 50 Lung Transplantation 50 Gets FDA Clearance 50 Adjunctive Therapy 50 Help Detect 50 rFactor XIII 50 Regimens 50 Breast Cancer Patients 50 Inflammatory Bowel Diseases 50 Phase III multicenter 50 Potent Antiviral Activity 50 Circulatory Support 50 Randomized Double Blind 50 Ion Channels 50 Transcatheter Valve 50 Brain Tumor Therapy 50 Vaccine Candidate 50 Pancreas Cancer 50 Rhinosinusitis 50 Pirfenidone 50 DOR BioPharma Announces 50 Vaccine Adjuvants 50 Wound Healing 50 Preclinical Clinical 50 Pregnancy Linked 50 Uterine Fibroid 50 Diabetic Foot 50 Archexin 50 Specialty Pharmaceutical 50 Cholesterol Lowering Drug 50 Randomized Clinical Trials 50 Cognitive Problems 50 Marrow Transplant 50 Wound Care Management 50 Adaptive Clinical Trials 50 Tibotec BVBA 50 Bazedoxifene 50 Nucleic Acids 50 Oral Presentation 50 Male Fertility 50 Renal Failure 50 Pneumococcal Conjugate Vaccine 50 Demonstrates Significant 50 Endovascular Valve Edge 50 Innate Immune 50 Partnering Agreements 50 Vicriviroc 50 Respiratory Viruses 50 Infertility Treatment 50 Poster Presentation 50 Metastatic Cancer 50 Intensive Care Medicine 50 Geriatric Medicine 50 Blood Transfusions 50 Antiviral Drugs 50 Blood Pressure Monitoring 50 Primary Immunodeficiencies 50 Stent Placement 50 Hedgehog Pathway 50 Teva Provides Update 50 Insulin Pen 50 WorldHeart Announces 50 Relapsed Refractory 50 Darbepoetin Alfa 50 Neural Stem Cells 50 Potent Anti 50 Randomized Phase III 50 Genetic Counseling 50 Artificial Organs 50 Artery Disease 50 Delcath Phase III 50 Combo Therapy 50 ARRY # 50 pralatrexate injection folate analogue 50 Vulnerable Plaque 50 Arch Neurol 50 Marillion Pharmaceuticals 50 Enzyme Replacement Therapy 50 Migraine Drug 50 ASCO GI 50 DIA Annual Meeting 50 ReCell ® 50 Antiepileptic Drugs 50 Romidepsin 50 EVEREST II 50 Fibromyalgia Syndrome 50 Complicated Skin 50 Cell Lymphoma 50 Malignant Mesothelioma 50 Immunosuppression 50 Short Stature 50 Vaccine Shows Promise 50 Detection Device 50 Clinical Trial Enrollment 50 Female Urology 50 Recurrent Prostate Cancer 50 developer Antisoma plc 50 Neurological Diseases 50 INDEPTH 50 Kidney Transplant Patients 50 PGx 50 Eliminate Health Disparities 50 Adjuvanted 50 Submits Biologics License Application 50 Welichem 50 Migraine Treatment 50 Efficacy Trial 50 Prognostic Value 50 Hematologist 50 Interventional Cardiologists 50 Cognitive Impairment 50 Acute Treatment 50 Breast Cancer Metastasis

Back to home page